Study type:
Risk communication/perception study
(practical study)
Clinicians' views on neuromodulation as a treatment for eating disorders: A qualitative study
risk
By:
Dalton B, Dornik J, McClelland J, Bartholdy S, Kekic M, Campbell IC, Schmidt U
Published in: Neuropsychiatr 2021; 35 (2): 84-91
Risk perception
Endpoint
- knowledge, safety and ethical concerns application of rTMS, tDCS and DBS for treatment of eating disorder
Considered exposure sources
Investigated group
18 clinicians from a specialist Eating Disorder Service in London, UK, took part in a survey..